Moreover, the regulator for breast cancer cell metabolism was identified to be the intracellular form rather than the secreted form of CYTL1, because ΔCYTL1 lacks the 1-22 aa signal peptide, but not rhCYTL1, affected glycolysis. Here, CYTL1 is linked to breast carcinoma.